181 related articles for article (PubMed ID: 30649685)
1. Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood-brain barrier damage.
Bavaro DF; Calamo A; Lepore L; Fabrizio C; Saracino A; Angarano G; Monno L
Infection; 2019 Jun; 47(3):441-446. PubMed ID: 30649685
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
[TBL] [Abstract][Full Text] [Related]
3. Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana.
Kelentse N; Moyo S; Mogwele M; Lechiile K; Moraka NO; Maruapula D; Seatla KK; Esele L; Molebatsi K; Leeme TB; Lawrence DS; Musonda R; Kasvosve I; Harrison TS; Jarvis JN; Gaseitsiwe S
Medicine (Baltimore); 2020 Oct; 99(41):e22606. PubMed ID: 33031315
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
Peluso MJ; Ferretti F; Peterson J; Lee E; Fuchs D; Boschini A; Gisslén M; Angoff N; Price RW; Cinque P; Spudich S
AIDS; 2012 Sep; 26(14):1765-74. PubMed ID: 22614889
[TBL] [Abstract][Full Text] [Related]
5. Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
Kugathasan R; Collier DA; Haddow LJ; El Bouzidi K; Edwards SG; Cartledge JD; Miller RF; Gupta RK
Clin Infect Dis; 2017 Apr; 64(8):1059-1065. PubMed ID: 28329096
[TBL] [Abstract][Full Text] [Related]
6. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
[TBL] [Abstract][Full Text] [Related]
7. [Clinical utility of HIV viral load assessment in cerebral spinal fluid, a case report].
Gutiérrez C; Chanqueo L; Bernal F; Ramírez A; Loureiro O; Vásquez P
Rev Chilena Infectol; 2018; 35(5):601-605. PubMed ID: 30725010
[TBL] [Abstract][Full Text] [Related]
8. Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.
St Bernard L; Abolade J; Mohri H; Markowitz M; Evering TH
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759323
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course.
Harrington PR; Schnell G; Letendre SL; Ritola K; Robertson K; Hall C; Burch CL; Jabara CB; Moore DT; Ellis RJ; Price RW; Swanstrom R
AIDS; 2009 May; 23(8):907-15. PubMed ID: 19414991
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
Soulie C; Grudé M; Descamps D; Amiel C; Morand-Joubert L; Raymond S; Pallier C; Bellecave P; Reigadas S; Trabaud MA; Delaugerre C; Montes B; Barin F; Ferré V; Jeulin H; Alloui C; Yerly S; Signori-Schmuck A; Guigon A; Fafi-Kremer S; Haïm-Boukobza S; Mirand A; Maillard A; Vallet S; Roussel C; Assoumou L; Calvez V; Flandre P; Marcelin AG;
J Antimicrob Chemother; 2017 Aug; 72(8):2351-2354. PubMed ID: 28472307
[TBL] [Abstract][Full Text] [Related]
11. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.
Cinque P; Presi S; Bestetti A; Pierotti C; Racca S; Boeri E; Morelli P; Carrera P; Ferrari M; Lazzarin A
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):377-83. PubMed ID: 11282006
[TBL] [Abstract][Full Text] [Related]
12. HIV-1C
Kelentse N; Moyo S; Mogwele ML; Ditshwanelo D; Mokaleng B; Moraka NO; Lechiile K; Leeme TB; Lawrence DS; Musonda R; Kasvosve I; Harrison TS; Jarvis JN; Gaseitsiwe S
Viruses; 2020 Dec; 12(12):. PubMed ID: 33297399
[TBL] [Abstract][Full Text] [Related]
13. Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.
Calcagno A; Romito A; Atzori C; Ghisetti V; Cardellino C; Audagnotto S; Scarvaglieri E; Lipani F; Imperiale D; Di Perri G; Bonora S
J Neuroimmune Pharmacol; 2017 Mar; 12(1):187-193. PubMed ID: 27826896
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.
Patton SM; Wang Q; Hulgan T; Connor JR; Jia P; Zhao Z; Letendre SL; Ellis RJ; Bush WS; Samuels DC; Franklin DR; Kaur H; Iudicello J; Grant I; Kallianpur AR
Fluids Barriers CNS; 2017 Apr; 14(1):11. PubMed ID: 28427421
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
[TBL] [Abstract][Full Text] [Related]
16. Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation.
Lupia T; Milia MG; Atzori C; Gianella S; Audagnotto S; Imperiale D; Mighetto L; Pirriatore V; Gregori G; Lipani F; Ghisetti V; Bonora S; Di Perri G; Calcagno A
AIDS; 2020 Mar; 34(3):373-380. PubMed ID: 31764071
[TBL] [Abstract][Full Text] [Related]
17. HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid.
Eggers CC; van Lunzen J; Buhk T; Stellbrink HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):259-64. PubMed ID: 10077174
[TBL] [Abstract][Full Text] [Related]
18. Analysis of correlation between cerebrospinal fluid and plasma HIV-1 RNA levels in patients with neurological opportunistic diseases.
Christo PP; Greco DB; Aleixo AW; Livramento JA
Rev Inst Med Trop Sao Paulo; 2011; 53(4):193-6. PubMed ID: 21915461
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy.
Donath M; Wolf T; Stürmer M; Herrmann E; Bickel M; Khaykin P; Göpel S; Gute P; Haberl A; de Leuw P; Schüttfort G; Berger A; Stephan C;
Med Microbiol Immunol; 2016 Dec; 205(6):575-583. PubMed ID: 27469377
[TBL] [Abstract][Full Text] [Related]
20. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
